The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Cannabinoid CB2 receptors in human brain inflammation
Open accessAbstract
The presence of functional cannabinoid CB 2 receptors in the CNS has provoked considerable controversy over the past few years. Formerly considered as an exclusively peripheral receptor, it is now accepted that it is also present in limited amounts and distinct locations in the brain of several animal species, including humans. Furthermore, the inducible nature of these receptors under neuroinflammatory conditions, in contrast to CB 1, makes them attractive targets for the development of novel therapeutic approaches. In fact, the undesired psychoactive effects caused by CB 1 activation have largely limited the clinical use of cannabinoid‐related compounds that act on these receptors. In this review some recent findings on the antiinflammatory properties of CB 2 receptors are presented, as well as new perspectives that have been obtained based on studies of human postmortem brain samples. In addition, various working hypotheses are also proposed and discussed. British Journal of Pharmacology (2008) 153, 277–285; doi:10.1038/sj.bjp.0707505; published online 15 October 2007
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,332
Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., & Weinshenker, B. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431307 · Cited by 2,899
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Multiple Sclerosis — The Plaque and Its Pathogenesis
Frohman, E. M., Racke, M. K., & Raine, C. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052130 · Cited by 1,740
Identification and Functional Characterization of Brainstem Cannabinoid CB2Receptors
Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science · doi:10.1126/science.1115740 · Cited by 1,470
Inflammation in Neurodegenerative Disease—A Double-Edged Sword
Wyss-Coray, T., & Mucke, L. (2002) · Neuron · doi:10.1016/s0896-6273(02)00794-8 · Cited by 1,235 · cited 1×
“…results in a massive local accumulation of inflammatory cytokines and reactive oxygen species (‘cytokine cycle’; Mrak and Griffin, 2005) and (iv) leads ultimately to neuronal death and massive loss of functional synapses, thus dramatically altering neurotransmission (Wyss-Coray and Mucke, 2002).”
BackgroundPathways to neuronal injury and apoptosis in HIV-associated dementia
Kaul, M., Garden, G. A., & Lipton, S. A. (2001) · Nature · doi:10.1038/35073667 · Cited by 1,210
Deciphering the Molecular Basis of Memory Failure in Alzheimer's Disease
Walsh, D. M., & Selkoe, D. J. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.010 · Cited by 1,207 · cited 2×
“‘amyloid hypothesis’ is now accepted (Walsh and Selkoe, 2004).”
BackgroundActivated microglia mediate neuronal cell injury via a nitric oxide mechanism
Chao, C. C., Hu, S., Molitor, T. W., Shaskan, E. G., & Peterson, P. K. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.8.2736 · Cited by 1,136
González-Scarano, F., & Martín-García, J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1527 · Cited by 1,097
Liu, B., & Hong, J.-S. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035048 · Cited by 1,095
Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death
Boje, K. M., & Arora, P. K. (1992) · Brain Research · doi:10.1016/0006-8993(92)91004-x · Cited by 944 · cited 1×
“These factors are produced by glial cells and invading immune cells (mainly reactive microglia) and can be deleterious to neurons (for review see Boje and Arora, 1992; Chao et al., 1992; Mc Guire et al., 2001; Liu and Hong, 2003).”
BackgroundAdult mouse astrocytes degrade amyloid-β in vitro and in situ
Wyss-Coray, T., Loike, J. D., Brionne, T. C., Lu, E., Anankov, R., Yan, F., Silverstein, S. C., & Husemann, J. (2003) · Nature Medicine · doi:10.1038/nm838 · Cited by 909 · cited 1×
“Wyss-Coray et al. (2003) showed that adult mouse astrocytes may also participate in this process, suggesting a new way for therapeutic intervention.”
BackgroundZajicek, J., Fox, P., Sanders, H., Wright, D., Vickery, J., Nunn, A., & Thompson, A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14738-1 · Cited by 827
Ramírez, B. G., Blázquez, C., del Pulgar, T. G., Guzmán, M., & de Ceballos, M. L. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4540-04.2005 · Cited by 785
Cannabinoid-based drugs as anti-inflammatory therapeutics
Klein, T. W. (2005) · Nature Reviews Immunology · doi:10.1038/nri1602 · Cited by 728
Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis
Rog, D. J., Nurmikko, T. J., Friede, T., & Young, C. A. (2005) · Neurology · doi:10.1212/01.wnl.0000176753.45410.8b · Cited by 679
Nonpsychotropic Cannabinoid Receptors Regulate Microglial Cell Migration
Walter, L., Franklin, A., Witting, A., Wade, C., Xie, Y., Kunos, G., Mackie, K., & Stella, N. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-04-01398.2003 · Cited by 665
Benito, C., Núñez, E., Tolón, R. M., Carrier, E. J., Rábano, A., Hillard, C. J., & Romero, J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-35-11136.2003 · Cited by 624
Self-citationGlia and their cytokines in progression of neurodegeneration
Mrak, R. E., & Griffin, W. S. T. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.05.010 · Cited by 592
Early and Progressive Accumulation of Reactive Microglia in the Huntington Disease Brain
Sapp, E., Kegel, K. B., Aronin, N., Hashikawa, T., Uchiyama, Y., Tohyama, K., Bhide, P. G., Vonsattel, J. P., & Difiglia, M. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.2.161 · Cited by 540
Cannabinoids control spasticity and tremor in a multiple sclerosis model
Baker, D., Pryce, G., Croxford, J. L., Brown, P., Pertwee, R. G., Huffman, J. W., & Layward, L. (2000) · Nature · doi:10.1038/35003583 · Cited by 532
Secondary Cell Death and the Inflammatory Reaction After Dorsal Hemisection of the Rat Spinal Cord
Dusart, I., & Schwab, M. E. (1994) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1994.tb00983.x · Cited by 527
Yiangou, Y., Facer, P., Durrenberger, P., Chessell, I. P., Naylor, A., Bountra, C., Banati, R. R., & Anand, P. (2006) · BMC Neurology · doi:10.1186/1471-2377-6-12 · Cited by 509
Cartier, L., Hartley, O., Dubois-Dauphin, M., & Krause, K.-H. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.07.021 · Cited by 509
Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli
Maresz, K., Carrier, E. J., Ponomarev, E. D., Hillard, C. J., & Dittel, B. N. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03380.x · Cited by 482
Koenigsknecht-Talboo, J., & Landreth, G. E. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1808-05.2005 · Cited by 477
Eljaschewitsch, E., Witting, A., Mawrin, C., Lee, T., Schmidt, P. M., Wolf, S., Hoertnagl, H., Raine, C. S., Schneider-Stock, R., Nitsch, R., et al. (2006) · Neuron · doi:10.1016/j.neuron.2005.11.027 · Cited by 445
Zhang, J., Hoffert, C., Vu, H. K., Groblewski, T., Ahmad, S., & O'Donnell, D. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02704.x · Cited by 419
Molina-Holgado, E., Vela, J. M., Arévalo-Martı́n, A., Almazán, G., Molina-Holgado, F., Borrell, J., & Guaza, C. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-22-09742.2002 · Cited by 419
Anti‐inflammatory agents as a therapeutic approach to Alzheimer's disease
McGeer, P. L., & Rogers, J. (1992) · Neurology · doi:10.1212/wnl.42.2.447 · Cited by 406
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation
Ehrhart, J., Obregon, D., Mori, T., Hou, H., Sun, N., Bai, Y., Klein, T., Fernandez, F., Tan, J., & Shytle, R. D. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-29 · Cited by 377
Current Pharmacotherapy for Alzheimer's Disease
Lleó, A., Greenberg, S. M., & Growdon, J. H. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.57.121304.131442 · Cited by 345
Carlisle, S. J., Marciano-Cabral, F., Staab, A., Ludwick, C., & Cabral, G. A. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00147-3 · Cited by 344
Chopp, M., Zhang, R. L., Chen, H., Li, Y., Jiang, N., & Rusche, J. R. (1994) · Stroke · doi:10.1161/01.str.25.4.869 · Cited by 343
Shohami, E., Gallily, R., Mechoulam, R., Bass, R., & Ben-Hur, T. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00181-6 · Cited by 337
Carrier, E. J., Kearn, C. S., Barkmeier, A. J., Breese, N. M., Yang, W., Nithipatikom, K., Pfister, S. L., Campbell, W. B., & Hillard, C. J. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.4.999 · Cited by 336
Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up
Zajicek, J. P. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.070136 · Cited by 335
Núñez, E., Benito, C., Pazos, M. R., Barbachano, A., Fajardo, O., González, S., Tolón, R. M., & Romero, J. (2004) · Synapse · doi:10.1002/syn.20050 · Cited by 333
Self-citationTherapeutic Action of Cannabinoids in a Murine Model of Multiple Sclerosis
Arévalo-Martı́n, Á., Vela, J. M., Molina-Holgado, E., Borrell, J., & Guaza, C. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02511.2003 · Cited by 314
Central Nervous System Damage, Monocytes and Macrophages, and Neurological Disorders in AIDS
Williams, K. C., & Hickey, W. F. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142822 · Cited by 309
CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms
Beltramo, M., Bernardini, N., Bertorelli, R., Campanella, M., Nicolussi, E., Fredduzzi, S., & Reggiani, A. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04684.x · Cited by 290
Westlake, T. M., Howlett, A. C., Bonner, T. I., Matsuda, L. A., & Herkenham, M. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90511-8 · Cited by 283
Lynn, A. B., & Herkenham, M. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38654-4 · Cited by 276
Cannabinoids ablate release of TNFα in rat microglial cells stimulated with lypopolysaccharide
Facchinetti, F., Del Giudice, E., Furegato, S., Passarotto, M., & Leon, A. (2003) · Glia · doi:10.1002/glia.10177 · Cited by 275
Pathogenesis of tissue injury in MS lesions
Trapp, B. D., Bö, L., Mörk, S., & Chang, A. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00081-8 · Cited by 259
Benito, C., Romero, J. P., Tolón, R. M., Clemente, D., Docagne, F., Hillard, C. J., Guaza, C., & Romero, J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4814-06.2007 · Cited by 256
Self-citationCannabinoids and the immune system: Potential for the treatment of inflammatory diseases?
Croxford, J. L., & Yamamura, T. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.04.023 · Cited by 255
Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells
Puffenbarger, R. A., Boothe, A. C., & Cabral, G. A. (2000) · Glia · doi:10.1002/(sici)1098-1136(20000101)29:1<58::aid-glia6>3.0.co;2-w · Cited by 248
Klegeris, A., Bissonnette, C. J., & McGeer, P. L. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705304 · Cited by 246
Sheng, W. S., Hu, S., Min, X., Cabral, G. A., Lokensgard, J. R., & Peterson, P. K. (2005) · Glia · doi:10.1002/glia.20108 · Cited by 245
Cannabinoid receptors in microglia of the central nervous system: immune functional relevance
Cabral, G. A., & Marciano-Cabral, F. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0405216 · Cited by 240
Tumor Necrosis Factor α Is Toxic to Embryonic Mesencephalic Dopamine Neurons
McGuire, S. O., Ling, Z. D., Lipton, J. W., Sortwell, C. E., Collier, T. J., & Carvey, P. M. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7688 · Cited by 222
Cannabinoid signaling in glial cells
Stella, N. (2004) · Glia · doi:10.1002/glia.20084 · Cited by 219
The Cannabinoid System and Cytokine Network
Klein, T. W., Lane, B., Newton, C. A., & Friedman, H. (2000) · Proceedings of the Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.2000.22501.x · Cited by 214
The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease
Aisen, P. S. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00133-3 · Cited by 203
Δ9-Tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis
Lyman, W. D., Sonett, J. R., Brosnan, C. F., Elkin, R., & Bornstein, M. B. (1989) · Journal of Neuroimmunology · doi:10.1016/0165-5728(89)90075-1 · Cited by 200
Inflammation in Parkinson's disease.
McGeer, P. L., Yasojima, K., & McGeer, E. G. (2001) · PubMed · Cited by 197
Molina-Holgado, F., Pinteaux, E., Moore, J. D., Molina-Holgado, E., Guaza, C., Gibson, R. M., & Rothwell, N. J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-16-06470.2003 · Cited by 192
Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia
Walther, S., Mahlberg, R., Eichmann, U., & Kunz, D. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0343-1 · Cited by 189
Oxidative stress and neuroAIDS: triggers, modulators and novel antioxidants
Mollace, V., Nottet, H. S. L. M., Clayette, P., Turco, M. C., Muscoli, C., Salvemini, D., & Perno, C. F. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01819-1 · Cited by 187
van der Laan, L. J. W., Ruuls, S. R., Weber, K. S., Lodder, I. J., Döpp, E. A., & Dijkstra, C. D. (1996) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00110-5 · Cited by 165
Benito, C., Kim, W.-K., Chavarría, I., Hillard, C. J., Mackie, K., Tolón, R. M., Williams, K., & Romero, J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3923-04.2005 · Cited by 162
Self-citationMicroglia and the Immune Pathology of Alzheimer Disease
Giulian, D. (1999) · The American Journal of Human Genetics · doi:10.1086/302477 · Cited by 148
Molina‐Holgado, F., Molina‐Holgado, E., Guaza, C., & Rothwell, N. J. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10165 · Cited by 148
Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis
Mestre, L., Correa, F., Arévalo‐Martín, Á., Molina‐Holgado, E., Valenti, M., Ortar, G., Marzo, V. D., & Guaza, C. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02979.x · Cited by 144
Ashton, J. C., Rahman, R. M. A., Nair, S. M., Sutherland, B. A., Glass, M., & Appleton, I. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.10.053 · Cited by 142
Inflammation in multiple sclerosis: the good, the bad, and the complex
Martino, G., Adorini, L., Rieckmann, P., Hillert, J., Kallmann, B., Comi, G., & Filippi, M. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00223-5 · Cited by 142
Ortega‐Gutiérrez, S., Molina‐Holgado, E., Arévalo‐Martín, Á., Correa, F., Viso, A., López-Rodríguez, M. L., Marzo, V. D., & Guaza, C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2464fje · Cited by 135
Functional neuroanatomy of the endocannabinoid system
Pazos, M. R., NUNEZ, E., Benito, C., Tolón, R. M., & Romero, J. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.030 · Cited by 131
Self-citationMosley, K., & Cuzner, M. L. (1996) · Neurochemical Research · doi:10.1007/bf02527713 · Cited by 123
Activation of adult human derived microglia by myelin phagocytosis in vitro
Williams, K. C., Ulvestad, E., Waage, A., Antel, J. P., & McLaurin, J. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490380409 · Cited by 121
Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes
Ghosh, S. T., Preet, A., Groopman, J. E., & Ganju, R. K. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.01.005 · Cited by 120
Köfalvi, A. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3 · Cited by 116
Franklin, A., & Stella, N. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)02074-0 · Cited by 111
Anandamide suppresses nitric oxide and TNF-α responses to Theilerʼs virus or endotoxin in astrocytes
Molina‐Holgado, F., Lledó, A., & Guaza, C. (1997) · Neuroreport · doi:10.1097/00001756-199705260-00027 · Cited by 110
Docagne, F., Muñetón‐Gómez, V. C., Clemente, D., Ali, C., Loría, F., Correa, F., Hernangómez, M., Mestre, L., Vivien, D., & Guaza, C. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.12.005 · Cited by 109
Ortega‐Gutiérrez, S., Molina‐Holgado, E., & Guaza, C. (2005) · Glia · doi:10.1002/glia.20229 · Cited by 109
Fernández‐López, D., Martínez-Orgado, J. A., Núñez, E., Romero, J., Lorenzo, P. L., Moro, M. Á., & Lizasoaín, I. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000228839.00122.6c · Cited by 106
Self-citationMolina‐Holgado, F., Molina‐Holgado, E., & Guaza, C. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00851-5 · Cited by 106
Emerging properties of cannabinoid medicines in management of multiple sclerosis
Pryce, G., & Baker, D. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.03.006 · Cited by 85
The Endocannabinoid System and Alzheimer’s Disease
Benito, C., Núñez, E., Pazos, M. R., Tolón, R. M., & Romero, J. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-8006-8 · Cited by 62
Self-citationMukhopadhyay, S., Das, S., Williams, E. A., Moore, D., Jones, J. D., Zahm, D. S., Ndengele, M. M., Lechner, A. J., & Howlett, A. C. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.08.002 · Cited by 62
Cabral, G. A., Harmon, K. W. N., & Carlisle, S. J. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-47611-8_24 · Cited by 61
Kreutz, S., Koch, M., Ghadban, C., Korf, H., & Dehghani, F. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.08.010 · Cited by 54
Cannabinoids in neurodegeneration and neuroprotection
Fernández‐Ruíz, J., González, S. R., Romero, J., & Ramos, J. A. (2005) · Birkhäuser-Verlag eBooks · doi:10.1007/3-7643-7358-x_5 · Cited by 47
Self-citationNew directions towards safer and effective vaccines for Alzheimer's disease.
Goñi, F., & Sigurdsson, E. M. (2005) · PubMed · Cited by 25
Neuroinflammation and the Glial Endocannabinoid System
Benito, C., Tolón, R. M., Núñez, E., Pazos, M. R., & Romero, J. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3_16 · Cited by 6
Self-citationKhan (2000) · doi:10.1002/1531-8249(200008)48:2
(1997) · doi:10.1002/(sici)1099-1166(199709)12:9<913::aid-gps663>3.0.co;2-d
Cited by
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
Pacher, P., & Mechoulam, R. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.01.001 · Cited by 414
Modulating the endocannabinoid system in human health and disease – successes and failures
Pacher, P., & Kunos, G. (2013) · The FEBS Journal · doi:10.1111/febs.12260 · Cited by 405
A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease
Hampel, H., Caraci, F., Cuello, A. C., Caruso, G., Nisticò, R., Corbo, M., Baldacci, F., Toschi, N., Garaci, F., Chiesa, P. A., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00456 · Cited by 360
Lipid G Protein-coupled Receptor Ligand Identification Using β-Arrestin PathHunter™ Assay
Yin, H., Chu, A., Li, W., Wang, B., Shelton, F., Otero, F., Nguyen, D. G., Caldwell, J. S., & Chen, Y. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806516200 · Cited by 311
Rosenberg, E. C., Tsien, R. W., Whalley, B. J., & Devinsky, O. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0375-5 · Cited by 276
Metadata
- Authors
- Benito, C., Tolón, R. M., Pazos, M. R., Núñez, E., Castillo, A. I., & Romero, J.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2008-01
- Volume
- 153
- Issue
- 2
- Pages
- 277-285
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2018810438
- Cited by
- 291
- References
- 90
- FWCI
- 5.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.